Creatine kinase MB (CK-MB) is the isoenzyme of creatine kinase found mainly in heart muscle, where it makes up a much larger share of CK activity than in skeletal muscle. When heart muscle cells die, as in myocardial infarction, CK-MB is released into the blood. For decades it was the main laboratory marker of heart attack. Today cardiac troponin is the preferred biomarker because it is more sensitive and more specific. CK-MB is used when troponin is not available.
CK-MB is interpreted together with total CK: a CK-MB share of more than a few percent of total CK points to heart muscle as the source. Because CK-MB returns to normal within 2–3 days, it was historically used to detect a new infarction soon after a first one. The current universal definition of myocardial infarction relies on a rise and/or fall of cardiac troponin; when troponin is not available, CK-MB measured by mass assay is the best alternative.
Call emergency services immediately for chest pain or pressure lasting more than a few minutes, especially with breathlessness, sweating, nausea or pain spreading to the arm, neck or jaw. Do not wait for blood test results.
This article is for general information and does not replace a consultation with a doctor. Laboratory results must be interpreted by a physician together with symptoms and other tests.
Published on 29 April 2024